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Abstract
There is a strong correlation between aging and onset of idiopathic Parkinson's 
 disease, but little is known about whether cellular changes occur during normal aging 
that may explain this association. Here, proteomic and bioinformatic analysis was 
conducted on the substantia nigra (SN) of rats at four stages of life to  identify and 
quantify protein changes throughout aging. This analysis revealed that proteins asso-
ciated with cell adhesion, protein aggregation and oxidation-reduction are dysregu-
lated as early as middle age in rats. Glial fibrillary acidic protein (GFAP) was identified 
as a network hub connecting the greatest number of proteins altered during aging. 
Furthermore, the isoform of GFAP expressed in the SN varied throughout life. 
However, the expression levels of the rate-limiting enzyme for dopamine produc-
tion, tyrosine hydroxylase (TH), were maintained even in the oldest animals, despite 
a reduction in the number of dopamine neurons in the SN pars compact(SNc) as aging 
progressed. This age-related increase in TH expression per neuron would likely to 
increase the vulnerability of neurons, since increased dopamine production would be 
an additional source of oxidative stress. This, in turn, would place a high demand on 
support systems from local astrocytes, which themselves show protein changes that 
could affect their functionality. Taken together, this study highlights key processes 
that are altered with age in the rat SN, each of which converges upon GFAP. These 
findings offer insight into the relationship between aging and increased challenges to 
neuronal viability, and indicate an important role for glial cells in the aging process.
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1  | INTRODUC TION
There is an inextricable link between aging and idiopathic Parkinson's 
disease (iPD). The typical onset of iPD is just after 60 years of age 
(Hindle, 2010), and there is a 10-fold increase in the occurrence of the 
disease between the ages of 50 and 80 (Van Den Eeden et al., 2003). 
Although aging is most certainly a risk factor, very little is known about 
whether changes occur in the region of the brain affected by iPD (i.e., 
the substantia nigra SNc) during normal aging that might make resident 
dopamine neurons there more susceptible to neurodegeneration.
What is known, however, is that there is a direct correlation 
between normal aging of the brain and an increased expression 
of markers of neurodegenerative conditions (Collier, Kanaan, & 
Kordower, 2011). A comparison of the proteome of healthy young 
and old humans, for example, found that proteins normally asso-
ciated with Alzheimer's disease (AD) were increased in expression 
in the orbitofrontal cortex as aging progressed (Pabba et al., 2017). 
In the nigrostriatal system, studies have shown that there is an in-
creased accumulation of alpha-synuclein in SNc dopamine neurons 
during normal aging (Chu & Kordower, 2007; Naskar, Mahadevan, 
Philip, & Alladi, 2019), and that ubiquitin positive inclusions (Lewy 
bodies) occur in the region during normal aging of both human and 
non-human primates (Beach et al., 2004; Siddiqi, Kemper, & Killiany, 
1999). What these studies highlight is that even in the absence of 
a degenerative condition, the proteome of the normal aging brain 
can be altered in a way that shows similarities to neurodegenerative 
disease.
At present, however, it is unclear whether the expression of 
proteins related to neurodegenerative disease in the aging brain are 
causative factors, or whether they indicate a response by cells to 
other—or earlier—protein changes. It is becoming increasingly ap-
parent though that the protein profile of all cells (not just the neu-
rons at risk) should be considered when exploring links between 
aging, protein alterations, and neuronal viability (Walker, 2018). In 
the seminal work by Peng et al. (2018), for example, aberrant ag-
gregation of the alpha-synuclein protein was shown to occur in oli-
godendrocytes in several regions of the brain. Differential effects 
on neuronal viability were observed with distinct conformational 
“strains” of alpha-synuclein in the aggregate, and the effects were 
dependent on the particular phenotype of cell and/or region of the 
brain the protein aggregates occurred within (Peng et al., 2018). 
When combined with studies from the aging brain, these findings 
suggest that proteome changes do occur during normal aging, and 
that changes in either neurons themselves or the cells that sur-
round them could make dopamine neurons in the SNc more sus-
ceptible to degeneration.
Quantitative proteomics technology provides an opportunity 
to clearly identify and quantify alterations in the expression of 
individual proteins and pathways in cells and tissues throughout 
aging. Here, we have used iTRAQTM-based proteomics analysis 
to quantitatively compare the proteome of the SN of rats at four 
stages of life to identify age-related changes in protein expres-
sion. Bioinformatics analysis of the proteomics data revealed an 
age-related differential expression of proteins associated with 
protein aggregation, oxidation-reduction, and astrocyte function. 
Interestingly, the glial fibrillary acidic protein (GFAP) formed the 
center of a network of proteins differentially expressed with age. 
Further analyses revealed that GFAP-delta, an isoform known to 
negatively affect astrocyte function, was increased in expression 
in middle-aged rats. This pattern of expression occurred con-
comitantly with dopamine neurons becoming reduced in number, 
while increasing in size and maintaining tyrosine hydroxylase (TH) 
expression levels in the SN. Taken together, these results add to 
the growing concept of a “pre-parkinsonian” state existing in the 
SN during aging (Collier et al., 2011; Collier, Kanaan, & Kordower, 
2017), and suggests that normal aging may create a protein pro-
file that challenges dopamine neuron viability and contributes to 
age-related vulnerability to neurodegenerative disease.
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Significance
Neurodegenerative diseases are associated with aging. 
However, it is currently unclear what changes during normal 
aging that makes these diseases more likely. The research 
conducted here has identified changes that occur during 
normal aging of the region of the brain that degenerates in 
Parkinson's disease. This has detailed alterations of a network 
of proteins, the greatest number of which is associated with 
one glial fibrillary acidic protein that is found specifically in 
support cells (glia). These results provide insight into how 
cells in the brain change during normal aging, and how these 
changes could lessen the ability of neurons to survive.
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2  | MATERIAL S AND METHODS
2.1 | Animals
All animal experiments were performed following guidelines estab-
lished by the Animal Welfare and Ethical Review Body (AWERB) at 
Keele University and conducted under the licensed authority of the 
UK Home Office (PPL40/3556). Animals were maintained in a 12/12-
hr light/dark cycle at a stable room temperature (RT; 22 ± 1°C), and 
were given free access to food, water, and environmentally enriching 
articles.
For the purpose of comparative analyses, male and female 
Sprague Dawley rats (RRID:MGI:5651135) were grouped into four 
experimental groups: postnatal day 14 rats (were considered “juve-
nile”), 8-month-old rats (“young adult”), 16-month-old rats (“middle 
age”), and 21- to 25-month-old rats (“old”).
2.2 | Tissue extraction and preparation
Rats were killed with an overdose of pentobarbitone anesthetic 
(0.5 ml/100 g) via an intraperitoneal injection, and transcardially 
perfused with ice-cold sterile 0.9% sodium chloride (saline). Brain 
specimens were removed rapidly and cut in half along the sagittal 
midline. The right hemisphere was used for proteomics and Western 
blotting, while the left hemisphere was kept for immunohistochem-
istry (IHC) analyses. To obtain protein samples, the SNc region was 
individually dissected from each right hemibrain after 0.5-mm thick 
coronal slices were made in the saline-infused specimen. Using the 
medial terminal nucleus (MTN) of the accessory optic tract as a guide 
(Winkler, Sauer, Lee, & Björklund, 1996), a region was selected to 
highly enrich the samples for the SNc region. To exclude tissue from 
the ventral tegmental area and pars reticulata nuclei, only tissue that 
was lateral to the MTN and dorsal to the midbrain bulge (represent-
ing pars reticulata) was used for proteomics processing. Although it 
is possible that some adjacent reticulata and/or VTA region could be 
included in these samples, we refer to the samples simply as “sub-
stantia nigra pars compacta” or “SNc” due to their high enrichment of 
the SNc region and the very close association of the surrounding tis-
sue to the SNc (i.e., adjacent regions which could affect the milieu of 
the SNc itself). The left hemibrain specimens were fixed by immer-
sion in a 4.0% solution of paraformaldehyde (PFA) in 1× Tris-buffered 
saline (TBS) overnight, and cryoprotected in a 30% sucrose solution 
in TBS until “sunk” (saturated) for sectioning.
2.3 | Protein extraction
Four animals per age group (two males and two females) were used 
for quantitative proteomics analysis and Western blotting. To mini-
mize sample losses due to the small size of SNc tissue, the four sam-
ples within each experimental group (juvenile, young adult, middle 
age, or old) were pooled before protein extraction. Pooled samples 
of each experimental group were then homogenized in four volumes 
(w/v) of 6M urea, 2M thiourea, 2% CHAPS, and 0.5% sodium dode-
cyl sulfate (SDS) using a pellet pestle (Fuller, Hurtado, Wishart, & 
Gates, 2014). Samples were left on ice for 10 min, followed by a brief 
sonication. Samples were subsequently left on ice for an additional 
10 min, followed by centrifugation at 13,000g for 10 min at 4°C. The 
extracted proteins in the resulting supernatants were precipitated 
in six volumes of ice-cold acetone overnight at −20°C. The next day, 
samples were centrifuged at 13,000g for 10 min at 4°C, and each 
pellet resuspended in 200 µl of 500 mM tetraethylammonium bro-
mide (TEAB) in ultrapure water (Chromasolve) for mass spectrom-
etry analysis. For Western blotting, total protein was extracted from 
individual SNc samples (without pooling) by homogenizing the tissue 
in 200 µl of cold RIPA buffer (Sigma, #R0278) with Halt™ protease 
EDTA-free inhibitor cocktail (ThermoFisher Scientific, #87785) using 
a pellet pestle (20 strokes). Samples were left on ice for 10 min, fol-
lowed by sonication. Samples were then placed on ice for an addi-
tional 10 min and then centrifuged at 13,000g for 10 min at 4°C. The 
protein concentration from each was quantified using a Bradford 
protein assay (Bradford, 1976).
2.4 | Mass spectrometry analysis
Samples were prepared for mass spectrometry analysis according 
to the protocol described in the isobaric tags for relative and ab-
solute quantitation (iTRAQTM) labelling kit (Biotech, 2016; Applied 
Biosystems, Foster City, CA, USA). Reduction of proteins and block-
ing of cysteine residues were performed using the reagents and 
protocol of the iTRAQTM labelling kit. Proteins were then digested 
with sequencing grade modified trypsin (5 µg/100 µg of protein, 
Promega, #V5113) overnight at 37°C, followed by drying in a cen-
trifugal vacuum concentrator to reduce the volume of the sample 
digest for maximal labeling efficiency. Each tag was incubated with 
85 µg of the total protein and any remaining protein extract was 
kept at −80°C for future Western blotting. Peptides were labeled 
with 4-plex iTRAQTM tagging reagents according to the protocol in 
the iTRAQTM kit, and were assigned to each sample group as follows: 
114-juvenile, 115-young adult, 116-middle age, 117-old.
High pH reverse-phase liquid chromatography (RPLC) fraction-
ation and liquid chromatography-tandem mass spectrometry anal-
ysis were conducted as described previously (Šoltić et al., 2019). 
Briefly, iTRAQTM labeled peptides were combined into one tube, 
concentrated using a vacuum concentrator, and then resuspended 
in 100 µl of 10 mM ammonium formate (NH4HCO2), 2% acetonitrile 
(MeCN), pH 10.0. The peptides were then fractionated by high pH 
RPLC using a C18 column (XBridge C18 5 µm, 4.6 × 100 mm, Waters) 
to give 12 fractions. The pooled fractions were concentrated in a 
vacuum concentrator and resuspended in 30 µl of 0.1% of formic 
acid (FA).
One third of each fraction containing the labeled peptides was 
analyzed by mass spectrometry using a TripleTOF 5600+ tandem 
mass spectrometer (AB Sciex), controlled by Analyst® TF software 
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(AB Sciex), and coupled to a NANOSpray II source. The raw mass 
spectrometry data file was analyzed by ProteinPilot software, ver-
sion 5.0.1.0 (Applied Biosystems) with the ParagonTM database 
search and Pro GroupTM Algorithm using the UniProtKB/Swiss-Prot 
FASTA database (RRID:SCR_004946). The general ParagonTM search 
analysis parameters were: type “iTRAQTM 4plex (Peptide Labeled)”, 
cysteine alkylation “MMTS”, digestion “trypsin” as the cleavage 
enzyme, instrument “TripleTOF”, and species “Rattus norvergicus” 
for sample parameters; processing parameters were specified as 
“quantitative”, “bias correction”, “background correction”; “thorough 
ID” and “biological modifications”. Proteins that showed a protein 
threshold >5 were used for the Pro Group Algorithm to calculate 
the relative quantification of the protein expression. The data that 
support the findings of this study are available in the supplementary 
material of this article.
2.5 | Bioinformatics analysis of differentially 
expressed proteins
The Database for Annotation, Visualization, and Integrated 
Discovery (DAVID; Huang, Sherman, & Lempicki, 2009a, 2009b; 
RRID:SCR_001881) platform was used to investigate the likely func-
tion of proteins that were differentially expressed in each compari-
son (https://david.ncifc rf.gov/). Gene Ontology (GO) analysis was 
conducted to include terms that had at least three annotated pro-
teins and a p-value ≤ 0.05. Redundant terms were combined into 
one term. The Search Tool for the Retrieval of Interacting Genes/
Proteins (STRING) 11 (Szklarczyk et al., 2017) (RRID:SCR_005223) 
was used to identify statistically significant interactions between 
proteins. Association network analysis was performed with medium 
confidence (0.400) interaction score to exclude false positive results.
2.6 | Western blotting
Protein extracts were incubated with an equal volume of 2× SDS 
sample buffer (0.125 M Tris-HCl, 20% glycerol, 4% SDS, 0.004% 
bromophenol blue, 5% 2-mercaptoethanol in ultrapure water, 
pH 6.8) for 5 min at 95°C. Samples were centrifugated at 16,000g 
for 1 min at 4°C and loaded onto the 4%–20% Mini-PROTEAN TGX™ 
Precast polyacrylamide Protein gels (Bio-Rad, #4561096) (14 µg of 
total protein per lane). Dual Color Standards (Bio-Rad, #1610374) 
were loaded for molecular weight estimation. Proteins were sepa-
rated by sodium dodecyl sulfate polyacrylamide gel electropho-
resis (SDS-PAGE) in a tank containing running buffer (25 mM Tris, 
190 nM glycine, 0.1% SDS in ultrapure water, pH 8.3) at constant 
voltage (200 V), between 1 and 3 hr depending of the molecular 
weight of the protein of interest. The separating gel was removed 
and a piece of gel without the region that contains the protein of 
interest was cut and stained with Coomassie Brilliant Blue R-250 
Staining solution (Bio-Rad, #1610436) as a loading control for the 
total amount of protein in each lane. Proteins in the other part of 
the gel were transferred by electrophoresis to the nitrocellulose 
membrane at constant milliampere (100 mA) overnight at 4°C in 
a tank containing 192 mM glycine, 25 mM Trizma base in 1 L ul-
trapure water with addition of 0.5 ml 20% SDS for proteins larger 
than 80 kDa. Membranes were stained with Ponceau S solution 
(Sigma, #P7170) to check the quality of the transfer, before blocking 
with 5% milk powder dissolved in Tris-buffered saline with tween 
(TBST) at RT for 30 min. Membranes were then incubated with 
primary antibodies to GFAP or TH (GFAP, Cell signalling (12389), 
RRID:AB_2631098; GFAP, Biolegend (644701), RRID:AB_2109791; 
GFAP-delta, Abcam (93251), RRID:AB_11145309; TH, Millipore/
Merck (ab152), RRID:AB_390204; Supplementary File S1) in 5% 
milk/TBST overnight at 4°C with shaking. Membranes were washed 
three times with TBST (5 min each wash) and incubated with 
HRP-conjugated secondary antibodies (anti-rabbit, ThermoFisher 
Scientific (31460), RRID:AB_228341; anti-mouse, ThermoFisher 
Scientific (31430), RRID:AB_228307; Supplementary File S2) in anti-
body solution at RT for 1 hr with shaking. Membranes were washed 
again three times with TBST and incubated with Clarity Western 
ECL Substrate (Bio-Rad, #1705061) or SuperSignal West Femto 
(ThermoFisherScientific, #34094) for 5 min. Blots and gels stained 
with Coomassie were imaged with a CCD system (FluorChem M sys-
tem, ProteinSimple). Densitometry measurements of antibody reac-
tive bands were obtained using Fiji/ImageJ software (https://imagej.
nih.gov/; RRID:SCR_003070) and were normalized to densitometry 
measurements of the Coomassie stained gel. Uncropped blots and 
stained gels are provided within the Supplementary file.
2.7 | IHC analysis
Fixed left hemibrains were mounted onto a microtome with Bright 
Cryo-M-Bed embedding compound (Bright Instrument Company) 
and sliced in 40 µm coronal sections from a region approximately 
−4.3 mm to −7.0 mm in relation to bregma (Paxinos & Watson, 2005). 
Each section was collected consecutively in six wells of a 24-well cul-
ture plate containing antifreeze cryoprotectant solution (30% eth-
ylene glycol and 30% glycerol in 0.2 M phosphate buffer) and were 
subsequently stored at −20°C. For IHC, one of every six sections 
through the mesencephalic region was processed. This separated 
sections analyzed by approximately 200 µm to assure that no cell 
was counted more than once for statistical analyses. Endogenous 
peroxidase activity was blocked by incubating sections with a solu-
tion containing 10% methanol, 10% hydrogen peroxide in TBS for 
30 min. After rinsing three times with TBS (5 min each), nonspecific 
binding sites were blocked in a blocking solution containing 0.2% 
Triton X-100, 3% normal goat serum in TBS for 20 min. Sections 
were incubated with an anti-TH primary antibody (Millipore/Merck 
(ab152), RRID:AB_390204; Supplementary File S1) in blocking so-
lution overnight at 4°C, rinsed three times with TBS (5 min each) 
and incubated with the biotinylated secondary antibody (Vector 
Laboratories (PK-6101), RRID:AB_2336820; Supplementary File S2) 
in TBS for 2 hr at RT. Negative controls were produced by incubating 
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sections overnight in blocking solution alone, followed by incuba-
tion in biotinylated secondary (Supplementary File 3). After three 
TBS washes of 5 min each, sections were incubated in Vectastain 
Universal ABC Kit detection system (Vector Labs, #PK6101) for 
1 hr at RT. Subsequently, sections were washed three times with 
TBS (5 min each) and reacted using 3,3-diaminobenzidine tetrahy-
drochloride (DAB, Sigma, #D8100) as a chromogen. Sections were 
rinsed three times with TBS to stop the reaction and mounted onto 
slides. After drying, sections were dehydrated in a series of alcohol 
gradients (70% for 5 min, 96% for 5 min, 100% for 10 min), immersed 
in xylene for 10 min, and covered with a coverslip using DPX slide 
mounting medium (ThermoFisher Scientific). Images were captured 
using a Nikon Eclipse 80i microscope and Nikon camera connected 
to a computer with the NiS Elements software. Images were ana-
lyzed using Fiji/ImageJ software (https://imagej.nih.gov/). The total 
number of TH-positive neurons per (mm)2 in each section was tabu-
lated (i.e., all cells were counted in the SNc region of all sections) and 
the area of soma (expressed in µm2) of TH-positive neurons deter-
mined by drawing around each cell within the dorsal region of the 
SNc using the “area” tool in NiS Elements software. For both the cell 
number and soma measurements within one-in-six sections through 
the nigra region, dopamine neurons were only included in the analy-
sis if they were both TH-positive and it was possible to delimit the 
soma and proximal processes.
2.8 | Statistical analyses
Statistical analyses were performed using GraphPad Prism version 
7.01 (La Jolla, USA) (RRID:SCR_002798). To compare means among 
the four age groups of animals used, data were analyzed by one-
way analysis of variance (ANOVA) test, followed by Tukey's multiple 
comparisons testing. Differences between groups were statistically 
significant when the p-value was ≤ 0.05.
3  | RESULTS
3.1 | Quantitative proteomics analysis of the rat 
SNc at four stages of life
To determine whether the rat SNc proteome changes throughout 
aging, iTRAQTM quantitative proteomics analysis was used to com-
pare protein expression from four different ages (i.e., postnatal day 
14 (juvenile), 8 months old (young adult), 16 months old (middle 
age), and 21–25 months-old (old)). A total of 2,732 proteins were 
reliably identified with a 5% local false discovery rate (FDR; see 
Supplementary Tables S1–S3). For reliable quantification, proteins 
identified from fewer than three peptides were removed, followed 
by removal of proteins with fold-change ratios of <1.25 or >0.75, and 
finally, exclusion of proteins with a p-value of <0.05 assigned to their 
fold changes. This left the following number of proteins that met 
the criteria for differential expression: 599 proteins in the juvenile 
compared to young adult group, 31 proteins in the middle age com-
pared to the young adult group, 18 proteins in the old compared to 
middle age group, and 46 proteins in the old compared to young 
adult group (Supplementary Tables S4–S7). Review of the 599 pro-
teins differentially expressed in the juvenile compared to the young 
adult rat SNc group revealed an enrichment of proteins known to 
be associated with postnatal neurodevelopment (Fuller et al., 2015). 
Given the overrepresentation of features of normal development in 
the juvenile versus young adult group, the juvenile data set was ex-
cluded from further analyses to retain focus on proteome modifica-
tions related to the aging process in adulthood (i.e., middle vs. young 
adult, old vs. middle age, and old vs. young adult).
Comparison of the middle versus young adult, old versus mid-
dle age, and old versus young adult data sets (Supplementary 
Table S8) found that none of the proteins showed a consistent 
 direction of change across each of the three comparisons, but 
several proteins were found to be commonly altered across two 
comparisons (Figures 1 and 2). Proteins with increased expression 
(Figure 1) include eight that were consistently changed in the old and 
middle age groups compared to young adults (i.e., apolipoprotein E 
(APOE), ferritin light chain 1 (FTL1), hyaluronan and proteoglycan 
link protein 2 (HAPLN2), myelin-associated oligodendrocyte basic 
protein (MOBP), prosaposin (PSAP), quinoid dihydropteridine reduc-
tase (QDPR), ribosomal protein L14 (RPL14) and versican (VCAN) 
and two that were increased in the old age group compared to 
middle age and young adult groups (i.e., aspartoacylase (ASPA) and 
myelin oligodendrocyte glycoprotein (MOG)). Three of the 25 pro-
teins that were increased only in the middle age versus young adult 
comparison met the criteria for decreased expression in the other 
two comparisons (i.e., GFAP, huntingtin (HTT) and sodium channel, 
voltage-gated, type IV, beta subunit (SCN4B); Figure 2); meaning 
that they increased by middle age but reduced to young adult lev-
els again by old age. One of the seven proteins increased only in 
the old versus middle age comparison met the criteria for decreased 
expression in the other two comparisons (i.e., myosin phosphatase 
rho-interacting protein (MPRIP); Figure 2). Other proteins decreased 
with age (Figure 2) include two that were consistently changed in old 
and middle age compared to young (i.e., aldo-keto reductase family 
1, member B7 (AKR1B7) and transgelin (TAGLN)) and two proteins 
that were consistently changed in old compared to middle age and 
young adult rats (i.e., acetyl-Coenzyme A acyltransferase 2 (ACAA2) 
and myelin zero protein (MPZ)).
3.2 | Proteins associated with cell adhesion, protein 
aggregation, and oxidation-reduction are increased in 
expression with age in the rat SNc
GO analysis using the DAVID highlighted enriched GO biological and 
molecular processes relating to the proteins increased and decreased 
with age. These differentially expressed proteins (from Figures 1  
and 2) were then subjected to analysis using STRING 11 to identify 
any known associations between them. Comparison of the resulting 
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networks with the GO analysis output identified protein clusters as-
sociated with highly enriched molecular and/or biological processes. 
For proteins increased in expression (i.e., at one time point compared 
to a younger time point), enriched processes were associated with 
cell adhesion/extracellular matrix, and protein aggregation, which 
included two proteins that specifically mapped to “tau binding” and 
four that were also associated with oxidation-reduction (Figure 3). 
Proteins that were decreased in expression at an older compared to 
a younger time point (Figure 4) were associated with actin binding, 
metabolism, and astrocyte function (though proteins linked to the 
latter term, GFAP and vimentin (VIM), were only decreased in the old 
group compared to middle age group—i.e., they “peaked” at middle 
age before returning to young adult levels by old age).
3.3 | GFAP is a network hub among proteins 
differentially expressed with age, and shows 
differential isoform expression during aging
A key observation from the network analyses of proteins increased 
in expression at an aged time point was that GFAP was found to have 
the greatest number of connections to other differentially expressed 
proteins (Figure 3). In effect, GFAP is shown to be a network hub 
with experimentally proven links to proteins associated with both 
protein aggregation (i.e., alpha-crystallin B (CRYAB), HTT, and Ca2+/
calmodulin-dependent protein kinase II (CAMK2)) and cell adhesion 
(i.e., HAPLN2).
We next chose to focus on verifying GFAP expression levels, 
as GFAP is a marker of astrocytes which are cells that have long 
been known to provide vital support to neurons (for reviews see; 
Escartin, Guillemaud, & Carrillo-de Sauvage, 2019; Vernadakis, 
1988). Quantitative Western blotting of GFAP in protein extracts 
from individual SNc samples at different ages revealed a major 
band in all samples at the predicted molecular weight of 50 kDa 
(Figure 5a). Densitometry measurements of this band showed a 
trend of increased expression of GFAP in the middle age adults 
compared to the young adult and old age groups. Although this 
peak in expression was not statistically significant, it did match 
the trend seen in the proteomics data set (Figure 5b). In addition 
to the major 50 kDa band, three lower molecular weight bands 
were observed that were more prominent with progressive aging 
(Figure 5a). Densitometry measurements of all GFAP bands within 
F I G U R E  1   Summary of proteins increased in expression in the aging rat substantia nigra (SN). Proteins that met the criteria for increased 
expression in middle age versus young (blue), old age versus middle (orange), and old age versus young (grey) rat substantia nigra samples are 
summarized in a Venn diagram and bar charts. The ratios of proteins that met the criteria for increased expression in one comparison but not 
in others are also shown for reference in the bar charts but are given in light blue, light orange, and light grey, according to the inset legend
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each sample (see example area in red box, Figure 5a) revealed an 
increase of “total” GFAP expression with increasing age, with the 
79% increase between young adult and old samples being statis-
tically significant (p = 0.022; Figure 5c). We are confident that the 
extra bands are not degradation products resulting from handling 
and storage conditions because four out of five samples from the 
old rats were stored for the least amount of time before process-
ing (the fifth being stored for the shortest time out of all ages). 
In addition, tissue extraction and processing of all samples were 
undertaken at the same time and under identical conditions. We 
also ruled out the possibility of an antibody cross-reaction by a dif-
ferent commercially available monoclonal antibody against GFAP, 
which revealed a very similar distribution of bands (Figure 5d–f). 
The most plausible explanation for the additional bands, there-
fore, is that they represent different isoforms of GFAP and/or 
products of proteolytic cleavage of the canonical, 50 kDa, GFAP 
protein (Figure 6a). Both scenarios would produce peptides less 
easily identifiable by mass spectrometry compared to the canon-
ical, 50 kDa protein—i.e., the former would require identification 
of just one or two unique C-terminal peptides from each isoform 
(see example sequence alignment in Supplementary File S4), and 
the latter would reduce the number of trypsin-cleaved peptides of 
predictable mass for database searching (Figure 6b). This would 
explain why Western blotting measurements of the 50 kDa band 
matched the quantitative proteomics result whereas measure-
ment of “total” GFAP did not.
When considering the issue above, it came to our attention 
that both GFAP-alpha and GFAP-delta (otherwise known as GFAP-
epsilon; Hol & Pekny, 2015) isoforms are close in molecular weight 
(Figure 6a) and would be unlikely to resolve by Western blotting 
using a “pan” GFAP antibody. We were therefore interested to de-
termine the contribution of each isoform to the increased levels 
seen in middle age rats. A suitable antibody for detection of rat 
GFAP-alpha was not available, but analysis of the rat SNc samples 
with an antibody raised against the GFAP-delta isoform revealed a 
statistically significant peak of GFAP-delta expression in the SNc 
of the middle-aged group compared to samples from both young 
adult (p = 0.0002) and old age samples (p = 0.0008; Figure 5g,h). It 
F I G U R E  2   Summary of proteins decreased in expression in the aging rat SN. Proteins that met the criteria for decreased expression in 
middle age versus young (blue), old age versus middle (orange), and old age versus young (grey) rat SN samples are summarized in a Venn 
diagram and bar charts. The ratios of proteins that met the criteria for decreased expression in one comparison but not in others are also 
shown for reference in the bar charts but are given in light blue, light orange, and light grey, according to the inset legend
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is thus possible that when GFAP-alpha and delta are detected to-
gether with a “pan” GFAP antibody (as is the case in Figure 5a,d), a 
stronger signal from GFAP-alpha—which may either be unchanged 
across ages, or altered to a lesser extent—could partially mask de-
tection of changes to GFAP-delta that are shown here statistically 
to occur.
3.4 | TH expression levels in the rat SN remain 
unchanged throughout life
The bioinformatics analysis (above) indicated that proteins associ-
ated with cell adhesion and the extracellular matrix were increased 
in middle and old age compared to the young rat SNc group. We 
wondered whether this may represent an attempt by cells of the SNc 
to spread into or fill space, since an age-related decline in dopamine 
neuron number has been shown to occur in the SNc of a wide range 
of mammals including rats and primates using strict stereological 
methods (e.g., Collier et al., 2011; Sanchez et al., 2008; Figure 7). It 
was interesting to observe a potential contradiction from the prot-
eomics data; however, in that the expression levels of TH—a marker 
of dopamine neurons—in the rat SNc remained unchanged through-
out aging (Supplementary Tables S1–S3). This finding was verified 
by quantitative Western blotting (Figure 7a,b). We also quantified 
and compared the number and size of TH-positive neurons from 
the dorsal region of the SNc using IHC. In agreement with previous 
stereological studies (Collier et al., 2011; Sanchez et al., 2008), this 
showed a significant decrease in the number of dopamine neurons 
between the young adult (0.0004 ± 0.0002) stage and middle age 
(0.0003 ± 0.0001; p < 0.0001; Figure 7c,d). Measurements of the 
soma size of TH-positive neurons in the SNc, however, found that 
reduced dopamine neuron number was accompanied by a significant 
increase in the area of the soma of TH-positive neurons in both old 
(201 ± 50.53) and middle-aged (198.3 ± 51.85) rats compared to the 
young adult group (164 ± 35.89, p < 0.0001; Figure 7e,f). When com-
bined, these histological and proteomic findings suggest that dopa-
mine neurons reduce in number, but that surviving neurons increase 
in size and maintain TH expression (i.e., suggesting more dopamine 
production per neuron) during the aging process.
4  | DISCUSSION
Idiopathic PD is correlated with advancing age, and so here we have 
sought to determine whether changes occur within the proteome of 
the SNc region during normal aging to provide some clues into this 
F I G U R E  3   Protein network and Gene Ontology (GO) analyses of proteins increased in expression in the rat SN with increasing age. 
STRING 11 association network showing proteins that met the criteria for increased expression in the middle age versus young (blue); 
old age versus middle (orange); old age versus young (dark grey); old versus middle and middle versus young (brown); and old and middle 
versus young (light grey) rat SN with increasing age are shown. The type of association between proteins is indicated by the color (pink: 
experimentally determined interactors; light blue: interactors form curated database; grey: protein homology; black: co-expression; yellow: 
text-mining; dark blue: gene co-occurrence; green: gene neighborhood). GO analysis of these proteins using the Database for Annotation, 
Visualization, and Integrated Discovery (DAVID) revealed an enrichment of terms related to oxidative reduction, cell adhesion, extracellular 
matrix, tau binding, and protein aggregation (the latter term having been generated following consolidation of the terms identical protein 
binding and protein homodimerization activity)
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association. Collectively, proteomics and bioinformatics, combined 
with Western blotting and histological analyses, identified signifi-
cant proteome changes in the SNc of rats by 16 months of age. Such 
alterations at this age appear to be relatively “young” in terms of 
human years, as studies establishing relative age between animals 
indicate that 16 months in rats are equivalent to ~40 years in hu-
mans (Sengupta, 2013). When categorizing the protein changes that 
occur during aging, there appears to be an increase in proteins asso-
ciated with oxidation-reduction processes, protein aggregation, and 
cell adhesion/extracellular matrix (Figures 1 and 3). These changes 
occur concomitantly with reduced expression of proteins involved 
in astrocyte function, actin binding, and metabolism (Figures 2 
and 4). Analysis of the intermediate filament protein, GFAP, re-
vealed that it is a network hub for proteins differentially expressed 
throughout aging, and that GFAP isoform expression is altered dur-
ing normal aging. Interestingly, while there was a reduction in the 
number of dopamine neurons as aging progressed, the remaining 
dopamine neurons were significantly increased in size and the level 
of TH expression in the SNc region was maintained throughout all 
adult ages. When considered together, these findings suggest the 
potential for an insidious process of protein changes (starting by 
middle age) in the SNc that, over time, ultimately results in a protein 
profile among cells in the SNc that would challenge the viability of 
dopamine neurons.
4.1 | Proteins associated with oxidation-reduction 
processes, protein aggregation, and tau binding 
increase in expression during aging
Bioinformatics analysis revealed that proteins associated with re-
ducing oxidative stress are increased in expression at middle age 
(i.e., glutathione reductase (GSR) and carbonyl reductase 1—Cbr1), 
and in both middle and old ages (QDPR) compared to young adults 
(Figures 1 and 3). Interestingly, increased expression of these reduc-
tases, known to combat oxidative stress (Couto, Wood, & Barber, 
2016; Rashid, Haque, & Akbar, 2016; Si, Sun, & Gu, 2017; Xu et al., 
2014), occur in conjunction with increased expression of ferritin 
heavy chain 1 (FTH1), a subunit of ferritin whose accumulation re-
sults in poor iron sequestration in cells and cell death (Lewerenz, 
Ates, Methner, & Conrad, 2018). These changes may be particularly 
important in relation to the viability of SNc neurons as oxidative 
stressors and iron accumulation are both known to play a major role 
in age-related neuronal death (Liguori et al., 2018; Salminen & Paul, 
2014) and PD (Liu, Liang, & Soong, 2019; Sun et al., 2019; Wojtunik-
Kulesza, Oniszczuk, & Waksmundzka-Hajnos, 2019; for review see 
Reeve, Simcox, & Turnbull, 2014). The glutathione system is known 
to be key in protecting cells from ferroptosis (a non-apoptosis form 
of cell destruction; Cardoso, Hare, Bush, & Roberts, 2017). This is 
directly relevant to midbrain dopamine neurons where it has been 
F I G U R E  4   Protein network and Gene Ontology (GO) analyses of proteins decreased in expression in the rat SN with increasing age. 
STRING 11 association network showing proteins that met the criteria for decreased expression in the middle age versus young (blue); 
old age versus middle (orange); old age versus young (dark grey); old versus middle and middle versus young (brown); and old and middle 
versus young (light grey) rat SN with increasing age are shown. The type of association between proteins is indicated by the color (pink: 
experimentally determined interactors; light blue: interactors form curated database; grey: protein homology; black: co-expression; yellow: 
text-mining; dark blue: gene co-occurrence; green: gene neighborhood). GO analysis of these proteins using the Database for Annotation, 
Visualization, and Integrated Discovery (DAVID) revealed an enrichment of terms related to astrocyte function, metabolism, and actin 
binding
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shown that a depletion of glutathione activity enhances oxidative 
stress (via arachidonic acid) and promotes dopamine neuron death 
(Mytilineou, Kramer, & Yabut, 2002). In the future, therefore, it will 
be important to monitor changes in oxidative stress regulators and 
iron accumulation during normal human aging to explore the poten-
tial to modulate these cellular systems and nullify any age-related 
contribution to increased neuronal vulnerability.
It was also interesting to note that proteins associated with 
protein aggregation and, in particular, tau binding (i.e., apolipopro-
tein E (APOE) and bridging integrator 1 (BIN1)) are also increased 
in expression during normal aging of the SNc. The importance of 
protein aggregation to neural degeneration is well illustrated in 
the experiments by Roostaee, Beaudoin, Staskevicius, and Roucou 
(2013) which show that alpha-synuclein dimerization initiates the 
formation of aggregates and fibrils in neurons in vitro, and that 
neurotoxicity results in the brain of mice where this process is 
facilitated. While the processes of protein aggregation (in partic-
ular tau binding) have long been associated with AD (Gonzalez, 
Abud, Abud, Poon, & Gyly, 2017), findings are beginning to emerge 
showing that tau pathology is also associated with PD (for review 
see; Zhang et al., 2018). Recent work has shown that APOE, in 
particular, is elevated in patients with untreated (early) PD, and 
that the lipoprotein may provide a mechanism by which alpha- 
synuclein can be taken up into SN dopamine neurons 
F I G U R E  5   Western blotting of glial fibrillary acidic protein (GFAP) expression in the substantia nigra (SNc) of young adult, middle age, 
and old rats. (a) Representative Western blot showing the expression levels of GFAP in the SNc of young adult (n = 4), middle age (n = 4), 
and old rats (n = 5), detected with a rabbit monoclonal antibody from Cell Signalling Technology (#12389). A main band was detected in 
all samples at 50 kDa, with additional lower molecular weight bands present that were more intense in the samples from old rats. (b) The 
integrated density of measured GFAP 50 kDa band from (a), normalized to total protein (Coomassie stained gel), showed a non-statistically 
significant increase in the middle age samples compared to young adult (p = 0.0571) and old (p = 0.1398). (c) The integrated density of all 
measured GFAP bands from (a) (see example in red box for area of measurement), normalized to total protein (Coomassie stained gel), 
showed a statistically significant increase between the young adult and old samples (p = 0.0221). (d) Representative Western blot showing 
the expression levels of GFAP in the SN pars compact (SNc) of young adult (n = 4), middle age (n = 3), and old rats (n = 3), detected with 
a mouse monoclonal antibody from Biolegend (#644701). Similarly, to panel (a), A main band was detected in all samples at 50 kDa, with 
additional lower molecular weight bands present that were more intense in the samples from old rats. (e) The integrated density of measured 
GFAP 50 kDa band from (d), normalized to total protein (Coomassie stained gel), showed a non-statistically significant increase in the middle 
age samples compared to young adult (p = 0.1562) and old (p = 0.2218). (f) The integrated density of all measured GFAP bands from (D), 
normalized to total protein (Coomassie stained gel), showed a non-statistically significant increase between the young adult and old samples 
(p = 0.1119). (g) Representative Western blot showing the expression levels of GFAP-delta in the SN of young adult (n = 4), middle age (n = 3), 
and old rats (n = 5), detected with a rabbit polyclonal antibody from Abcam (#93251). (h) The integrated density of measured GFAP-delta 
from (g), normalized to total protein (Coomassie stained gel), showed a statistically significant increase in the middle age samples compared 
to young adult (182%; p = 0.0002) and a statistically significant decline from middle age to old samples (49%; p = 0.0008). Error bars 
represent standard deviation. *p < 0.05; ***p < 0.001
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(Paslawski et al., 2019). Similarly, though high expression levels of 
BIN1 has proven to be a good indicator of increased susceptibility 
to AD (Chapuis et al., 2013), studies examining the association of 
BIN1 and genetic contributors to PD (i.e., the glucocerebrosidase 
(GBA); Sidransky & Lopez, 2012) have shown that the age of onset 
of GBA-associated PD can be altered by BIN1 expression (Gan-Or 
et al., 2015). When combined, these studies suggest that there is 
some overlap in the proteins associated with AD and PD, and, in 
combination with the findings here, that there is growing evidence 
for a close association between abnormal protein expression in 
neurodegenerative disease and normal aging of the brain.
Understanding the interplay between oxidative processes 
and protein aggregation could also be useful for understanding 
and combating age-neuronal loss and neurodegenerative disease. 
Work by Rajagopal, Deb, Poddar, and Paul (2016), for example, 
looking at changes in protein dimerization in the cortex and hip-
pocampus (areas affected by AD) of normal rats up to 18 months 
old, showed that there is increased dimerization/aggregation of 
F I G U R E  6   Schematic diagrams summarizing glial fibrillary acidic protein (GFAP) variants and degradation products: (a) The GFAP protein 
has a head, rod, and tail domain, and the various GFAP isoforms differ according to their sequence and sequence length at the N- and/or 
C-terminal regions. The head domain (green) contains the exon 1; the rod domain is divided in four sub-regions (1A (exon 2), 1B (exon 3),  
2A (exon 4), 2B (exons 5 and 6)), separated by linker regions (black lines); and the tail domain contains exons 7 to 9. Only GFAP-alpha (α) 
(bold font) and GFAP-delta (δ) have known molecular weights in the rat (i.e., 49.9 kDa (Uniprot P47819-1) and 48.7 kDa (Uniprot KB–P47819-
2), respectively). NB. GFAPδ and ε have previously been referred to as the same isoform (Hol & Pekny, 2015), but a polyadenylation in 
exon 7a may mean that GFAPε should be considered as a separate isoform (Blechingberg, Lykke-Andersen, Jensen, Jørgensen, & Nielsen, 
2007). Where readily available in publications or protein databases, molecular weights of GFAP isoforms reported in mouse and human 
are shown in grey font (Hol & Pekny, 2015; Hol et al., 2003; Kamphuis et al., 2012, 2014). Evidence for the existence of isoforms shown 
without a corresponding molecular weight come from partial transcripts (summarized by Hol & Pekny, 2015). (b) Possible calpain and caspase 
proteolytic degradation products of GFAP are shown, along with their known (black) or predicted (grey) molecular weight. Known molecular 
weights were obtained from Lee et al. (2000) (calpain 1), Fujita et al. (1998) and Zhang et al. (2014) (calpain 2), Mouser, Head, Ha, and Rohn 
(2006) (caspase 3) and Chen, Hagemann, Quinlan, Messing, and Perng (2013) (caspase 6). Molecular weight predictions (for fragments not 
reported in the literature) were made using a protein molecular weight calculator (https://www.bioin forma tics.org/sms/prot_mw.html) 
without considering post-translational modifications. The molecular weight of GFAP fragments may vary according to the species, are here 
are indicated as follows: rat (*), mouse (+), or human (†) origin
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the phosphatase striatal-enriched tyrosine phosphatase (STEP—a 
phosphatase that protects neurons from excitotoxicity) during 
aging. This increased dimerization of STEP, causing a loss of its 
function, results in a depletion of glutathione and an increase in 
oxidative stress in the brain. When the glutathione system was 
enhanced through the application of N-acetyl cysteine, this was 
found to reduce the dimerization of STEP and stop negative down-
stream effects.
F I G U R E  7   Levels of tyrosine hydroxylase (TH) expression remain stable throughout aging, while the number of TH + neurons are 
reduced but increase in soma size: (a) Representative Western blot showing the expression levels of TH in the substantia nigra pars compact 
(SNc) of young adult (n = 4), middle age (n = 4), and old rats (n = 5), detected with a rabbit polyclonal antibody from Millipore/Merck (ab152). 
(b) The integrated density of the TH bands from (a), normalized to total protein (Coomassie stained gel), showed no significant difference 
in TH expression levels across each age group. (c and e) Representative anti-TH stained coronal sections taken from the SN at the rostral-
caudal level where the optic tract enters the midbrain. Boxes in images indicate area shown in high magnification in subsequent rows. (d and f) 
Statistical comparison of the average number of TH+ neurons per (mm)2 and the average area of TH+ cell soma (µm2) in the dorsal SNc 
(boxed area in middle row of c) of young adult, middle age, and old age rats. Size of scale bar shown in first image of each row. ***p < 0.01, 
****p < 0.001
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4.2 | The intermediate filament protein GFAP 
changes throughout aging
Here we have identified that GFAP links the greatest number of 
proteins altered during aging (Figure 3). Previous studies have in-
dicated that there is an increase in the expression of GFAP in the 
human SNc at old age (Jyothi et al., 2015). This matches the findings 
from the Western blotting here showing that the expression levels 
of GFAP gradually increase throughout the three adult stages ana-
lyzed (Figure 5). Examination of the GFAP-delta isoform specifically, 
however, found that there was a significant increase in its expression 
during middle age (in comparison to young adult and old-aged rats; 
Figure 5). This is important to note, as it highlights that changes can 
occur in astrocytes earlier than previously thought, and that changes 
in protein isoforms can be masked if analysis is conducted using 
“pan” GFAP antibodies alone.
Although the alpha isoform of GFAP is considered the canonical 
form of the protein, delta does occur in the brain but is typically 
expressed at significantly lower levels than alpha (<10%; Perng et al., 
2008), and is associated with disease states (e.g., astrocytomas; 
Choi, Kwak, Kim, Sheen, & Kang, 2009). When expression of the 
delta isoform is increased above 10% of total GFAP it can disrupt 
the assembly of intermediate filaments within astrocytes (particu-
larly the assembly of GFAP-alpha) and elicits an increase in alpha- 
crystallin B sedimentation (Perng et al., 2008). This sequence of 
events aligns well with the iTRAQTM results here showing that 
CRYAB also increases during aging along with GFAP-delta. This 
process is important to highlight because CRYAB sedimentation is 
known to cause protein aggregations that disrupt normal cell func-
tion, and its upregulated a feature of the post-mortem Parkinson's 
SNc (Liu et al., 2015). If sedimentation occurs in astrocytes during 
normal aging, it could negatively alter the supportive functions of as-
trocytes that are fundamental to dopamine neuron viability (Mena, 
Bernardo, Casarejos, Canals, & Rodríguez-Martín, 2002). This may 
be particularly important in relation to oxidative stress (highlighted 
above), where it is well established that neurons are highly depen-
dent on astrocytes for protection from oxidative stress, and (in some 
cases) may be the only source of antioxidation via glutathione trans-
ferase activity (Murphy et al., 2001). Interestingly, while postmor-
tem analyses of regions of the parkinsonian brain relatively spared 
from neurodegeneration (i.e., the caudate, putamen, and frontal 
cortex) show an increase in astrocyte activity and glutathione levels 
(Mythri et al., 2011), the proteomics analyses conducted here show 
a decrease in both glutathione transferase 3 and 4 during normal 
aging (Figures 1–4).
The role that astrocytes and the changing isoform of GFAP plays 
in the aging process, however, is complicated by the fact that there 
also appears to be a close relationship between protein homodi-
merization (abnormal protein aggregation) and GFAP-delta. Perng 
et al. (2008) noted that the delta tail of GFAP may in fact inhibit ho-
modimerization. This would make sense in light of the findings here 
showing that increases in protein aggregation occur at middle age, 
which overlaps with a period of significantly increased expression 
of the GFAP-delta isoform. This finding suggests the possibility 
that increases in the expression of the GFAP-delta may occur as a 
positive response to increased protein aggregation, adding to the 
list of protective responses by astrocytes in the brain. Whether as-
trocytes are becoming more dysfunctional through the increased 
expression of the GFAP-delta isoform or are attempting to com-
bat increases in protein aggregation in the SNc during aging is still 
unclear. In the future, it will be important to fully characterize the 
changes in astrocytes during aging and determine at what stage they 
occur. This could not only be useful for identifying markers of a “pre- 
parkinsonian” state (Collier et al., 2011), but may also help identify 
 contributors to age-related neuronal loss or endogenous responses 
meant to combat it.
4.3 | Dopamine neurons maintain TH expression 
levels in the SNc region during aging, even though 
neuronal numbers are significantly reduced and 
proteins associated with metabolism are decreased 
in expression
iTRAQTM and quantitative Western blotting of the rate-limiting 
enzyme for dopamine production, TH, showed that it was not al-
tered in expression during the aging process (Figure 7). This was 
somewhat surprising as it has long been established that there is 
a “normal” age-related decline in dopamine neuron numbers in 
rats and humans (Collier et al., 2017; Sanchez et al., 2008). Due 
to this, and because the by-products of dopamine production can 
have an impact on the oxidative stress levels of dopamine neu-
rons (for review; see Dias, Junn, & Mouradian, 2013), we sought 
to further characterize dopamine neurons in tissue sections taken 
from the same animals used for proteomics and Western blotting 
(Figure 7). When counting the number of TH-positive cell bodies 
in the core of the SNc in young adult, middle age, and old rats, 
we indeed found a decrease in the number of dopamine neurons 
between young adult versus middle age (Figure 7). Interestingly, 
however, when the size of these neuronal cell bodies was also 
measured, we found that there was a significant increase in the 
soma at progressive ages (Figure 7) similar to that seen in humans 
(Cabello, Thune, Pakkenberg, & Pakkenberg, 2002). When com-
bined, these findings suggest that there is an increased level of 
the dopamine synthesis pathway by fewer dopamine neurons in 
the SNc, presumably to maintain an appropriate “pool” of dopa-
mine for basal ganglia functioning (Zhai, Tanimura, Graves, Shen, 
& Surmeier, 2018). This possibility is supported by the fact that we 
have shown an age-related increase in QDPR, which is a known 
catalyst for tetrahydrobiopterin recycling and subsequent TH syn-
thesis (Breuer et al., 2019; Ishikawa et al., 2016). Any increase in 
dopamine synthesis would likely place a high demand on neuronal 
cells and astrocyte function to both produce neurotransmitter and 
control the stressors related to that production. This was some-
what confounding in the present analyses as proteins associated 
with cellular metabolism appear to be reduced in expression in 
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the SNc during aging (Figure 4). Whether metabolic reduction is 
due to cellular dysfunction or simply due to cell loss in the re-
gion is unclear, but such alterations conflict with the increases in 
protein expression in the region. Added to this is the finding that 
proteins associated with the extracellular matrix are also increased 
in expression during aging. This trend is in line with our past re-
search showing changes in the expression proteins related to the 
extracellular matrix in the striatum of rats after inducing dopamine 
neuron degeneration (Fuller et al., 2014). Such responses in the 
adult brain could represent an attempt to reorganize circuitry or 
cell connectivity, which has been shown to occur at the level of 
the dendritic spine during normal rodent aging (Davidson, Mejía-
Gómez, Jacobowitz, & Mostany, 2019).
4.4 | Aging presents a growing challenge to cell 
viability and function in the SNc
When taken together, the results of our study indicate that there are 
changes to the proteome of the normally aging rat SNc that would 
increasingly challenge the viability of cells in the region. Proteins re-
lated to oxidative stress, protein aggregation, and astrocytic func-
tion all become altered during aging; each of which are processes 
likely to negatively impact dopamine neuron survival. In particular, 
changes in the expression of proteins related to oxidative processes 
occur alongside alteration in the level of expression of GFAP and its 
isoforms. This would present further challenges to cell viability in 
the region as astrocytes are important to the homeostatic environ-
ment, particularly in relation to oxidative stress. This may be par-
ticularly important to consider in human aging and PD due to the 
fact that many human SNc dopamine neurons convert dopamine 
into a more stable form, neuromelanin. This reduction of dopamine 
to neuromelanin produces highly oxidative by-products and would 
add to the oxidative stresses brought on by normal aging. This ad-
ditive effect (brought on by normal aging and dopamine reduction) 
might explain why rats (and other mammals that do not produce 
neuromelanin) do not naturally show signs of sporadic PD during 
aging, and why there is a selective degeneration of neuromelanin 
containing neurons in PD (Hirsch, Graybiel, & Agid, 1988; Hirsch, 
Graybiel, & Agid, 1989; for reviews see Vila, 2019; Monzani et al., 
2019). Interestingly, the loss of neurons during normal aging (Cabell 
et al., 2002; and Figure 7) would increase the demand for more do-
pamine synthesis per remaining neuron (as suggested here), result-
ing in a cycle of increased oxidative stressors in the human SNc and 
further neuronal loss. If such an age-related cycle were accelerated 
(as suggested by Collier et al., 2011, 2017), it could produce more 
rapid destruction of dopamine neurons in the human SNc (Segura-
Aguilar et al., 2014; Zhang, Wang, & Wang, 2019) and result in a par-
kinsonian state.
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